Clinical trial Recruiting at 1 site Observational Ages 19 and up

Effects of aortic valve calcification on outcomes after valve replacement

Official title: Impact of Aortic Annulus Calcification on Long-Term Outcomes Following Transcatheter Aortic Valve Replacement: Scientific Association of Interventional Cardiology - Transcatheter Aortic Valve Replacement (SAINT-TAVR) Calcium Registry

Run by Eunpyeong St. Mary's Hospital · NCT06722066 · Data updated 2026-11-12

This study is testing how the amount of calcium buildup around the aortic valve affects the long-term health of people who have had a valve replacement for severe aortic stenosis.

Quick facts

Study typeObservational
Ages19 Years and up
SexAll
Enrollment500 (estimated)
SponsorEunpyeong St. Mary's Hospital
Academic / other
Locations1 site (Seoul)
StatusRecruiting
StartedOctober 2, 2024
Main results expectedDecember 2, 2031
Study endsOctober 2, 2034
Registry record updatedDecember 9, 2024
Trial IDNCT06722066 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 19 years or older who have undergone TAVR for severe aortic stenosis.

Probably not a fit

Patients who have not undergone TAVR or those who do not provide informed consent will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate the long-term effects of aortic valve annular calcification in patients who have undergone transcatheter aortic valve replacement (TAVR) for severe aortic stenosis. It will evaluate whether the degree of calcification prior to the procedure influences long-term clinical outcomes, including major adverse cardiovascular events and all-cause mortality, over a follow-up period of three years. Participants will have their pre-procedural imaging and clinical outcomes assessed to gather data on these relationships.

Why it matters

Potential benefit: If successful, this study could provide insights that improve patient selection and management strategies for TAVR, potentially enhancing long-term outcomes.

How similar studies have gone: While there may be studies on TAVR outcomes, this specific focus on aortic annulus calcification and its long-term effects appears to be a novel approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Adults aged 19 years or older.
2. Patients who have undergone transcatheter aortic valve replacement (TAVR) for severe aortic stenosis.
3. Individuals who have voluntarily provided written informed consent to participate.

Exclusion Criteria:

1\. Individuals who have not provided written informed consent for this study.

Where it's running

  • Division of Cardiology, Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea
    Seoul, South Korea
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.